-Sven Perner Researcher Activity Profile

Research Author Detailed Information 

Sven Perner Publication Rate By Year

Sven Perner has published 1 paper(s) in 2006, 12 paper(s) in 2007, 4 paper(s) in 2008, for a total of 17 research publications in total.

Sven S Perner Author Information

LAST NAME: perner

FIRST NAME: Sven

INITIALS: s

AFFILIATION:

Papers

Sven Perner's Publication Record

1. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Year Published: 2006
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, EBRC 442A, 221 Longwood Avenue, Boston, MA 02115-6110, USA.
2. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. Year Published: 2007
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115-6110, USA.
3. Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Year Published: 2007
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115-6110, USA.
4. [TMPRSS2-ETS gene fusion in prostate cancer] Year Published: 2007
Department of Pathology, Brigham & Women's Hospital/Harvard Medical School, 221 Longwood Avenue, EBRC 442A, Boston, MA 02115-6110, USA.
5. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. Year Published: 2007
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
6. Characterizing the cancer genome in lung adenocarcinoma. Year Published: 2007
Department of Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
7. Characterizing the cancer genome in lung adenocarcinoma. Year Published: 2007
Department of Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
8. [TMPRSS2-ETS gene fusion in prostate cancer] Year Published: 2007
Department of Pathology, Brigham & Women's Hospital/Harvard Medical School, 221 Longwood Avenue, EBRC 442A, Boston, MA 02115-6110, USA.
9. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Year Published: 2007
Broad Institute, Massachusetts Institute of Technology and Harvard University, 7 Cambridge Center, Cambridge, MA 02142, USA.
10. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. Year Published: 2007
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
11. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Year Published: 2007
Broad Institute, Massachusetts Institute of Technology and Harvard University, 7 Cambridge Center, Cambridge, MA 02142, USA.
12. Characterizing the cancer genome in lung adenocarcinoma. Year Published: 2007
Department of Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
13. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Year Published: 2007
Broad Institute, Massachusetts Institute of Technology and Harvard University, 7 Cambridge Center, Cambridge, MA 02142, USA.
14. Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Year Published: 2008
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 3rd Floor, 181 Longwood Avenue, Boston, MA 02115. lmucci@hsph.harvard.edu.
15. Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia. Year Published: 2008
16. Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Year Published: 2008
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. lmucci@hsph.harvard.edu
17. Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Year Published: 2008
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. lmucci@hsph.harvard.edu